Genomics 101

On-Demand Learning Modules

The RCIGM Genomics 101 course is designed to provide learners with a foundational knowledge of genomics and genomic medicine at the Rady Children’s Institute for Genomic Medicine. The series was created to equip learners with an overview of genomic medicine from start to finish. The modules explore recognizing the benefits and limitations of genetic tests currently available in the clinical setting to identifying and consenting a patient, and finally delivering a result.

The learning series will focus on the following areas:

  • Genome Biology and Genetic Tests
  • Whole Genome Sequencing
  • Clinical Genomic Medicine

Download Materials

Learning Objectives:

  • Describe the principles of genomic medicine and whole genome sequencing
  • Discuss the uses, benefits, and limitations of genomic testing technologies
  • Recognize when and how to refer patients for whole genome sequencing
  • Identify tools and other practical resources for implementation of whole genome sequencing
  • Determine early ascertainment for patients who may benefit from whole genome sequencing
  • Recognize how to collaborate with an interdisciplinary team of health professionals

Genomics 101 is made available as an on-demand pre-conference series to registered Frontiers participants.

Register for Frontiers

Physicians: CME CreditsUCSD Medical School logo

The University of California San Diego School of Medicine designates this enduring material for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of California San Diego School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This CME activity meets the requirements under California Assembly Bill 1195, continuing education and cultural linguistic competency.

This activity is intended for the Genomic Community.


It is the policy of the University of California San Diego School of Medicine to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms 1) altering the financial relationship with the commercial interest, 2) altering the individual’s control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose will be disqualified from participating in the CME activity.

The Genomics 101 course will be made available April 13, 2021, and will expire April 12, 2022.